Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

ARA-290 vs TB-500

TB-500, a synthetic version of thymosin beta-4's active fragment, promotes tissue regeneration through effects on cell migration and angiogenesis. It works more systemically than BPC-157. TB-500 Nerve protection, anti-inflammation Whole-tissue regeneration Sco

This comparison does not assign a generated winner or score.

  • TB-500, a synthetic version of thymosin beta-4's active fragment, promotes tissue regeneration through effects on cell migration and angiogenesis.
  • It works more systemically than BPC-157.
  • TB-500
  • Nerve protection, anti-inflammation
  • Whole-tissue regeneration
  • Scope
  • Neurovascular-focused
  • Systemic, cardiovascular, muscle
  • Angiogenesis
  • Via IRR activation
  • Directly increases VEGF production
  • Neuropathy, inflammatory conditions
  • General recovery, muscle injury
  • Subcutaneous daily
  • Subcutaneous 2x weekly typically
  • TB-500's strengths lie in general tissue regeneration and recovery. ARA-290's strengths lie specifically in nerve protection and inflammation control. For conditions involving both nerve damage and tissue injury, using both might provide complementary benefits.
More references

Related material

Comparison

ARA-290 vs other healing peptides

Researchers exploring tissue repair and pain relief have several peptide options. Understanding how ARA-290 compares to alternatives like BPC-157 and TB-500 helps with protocol pl…

View details →
Comparison

ARA-290 vs BPC-157

BPC-157, a 15-amino acid peptide derived from human gastric juice, has robust preclinical evidence for musculoskeletal repair, particularly tendons and ligaments. It also shows ne…

View details →